Prostate Cancer Treatment in India

  • Cost: $5,000–$18,000
  • Stay: 2–8 weeks
  • Success: 90–95% (localised)
  • Oncology
  • $5K–$18K
  • 2–8 weeks
  • 90–95% (localised)
$5,000–$18,000
Cost Range
2–8 weeks
Hospital Stay
90–95% (localised)
Success Rate
70%
Lower Cost vs Gulf
No Image

Prostate Cancer Treatment in India — Advanced, Precise, Affordable

Prostate cancer is among the most common cancers in men from the Gulf region, and India offers Da Vinci robotic-assisted radical prostatectomy, High-Intensity Focused Ultrasound (HIFU), brachytherapy, stereotactic body radiation therapy (SBRT), and androgen deprivation therapy. Robotic prostatectomy achieves precision cancer removal, minimal blood loss, nerve-sparing technique to preserve continence and sexual function, with just a 2–3 day hospital stay. HIFU is a completely non-invasive option using high-frequency ultrasound waves to destroy cancer cells without surgery — ideal for localised prostate cancer with minimal side effects.

Why India? Key Points

  • Robotic prostatectomy $6,000–$9,000 in India vs $25,000–$40,000 in the USA
  • HIFU non-invasive treatment available at select hospitals
  • Da Vinci robotic nerve-sparing prostatectomy — preserves continence
  • PSA testing and MRI-guided biopsy for accurate staging
  • Hormone therapy (ADT) drugs at 60–70% lower cost
  • Urological oncologists with 500+ robotic prostatectomies performed

Procedures Covered

  • Robotic Radical Prostatectomy (Da Vinci)
  • HIFU (High-Intensity Focused Ultrasound)
  • Radiation Therapy (IMRT/SBRT)
  • Brachytherapy (Seed Implants)
  • Androgen Deprivation Therapy (ADT)
  • Chemotherapy for Advanced Prostate Cancer

🏥 Best Hospitals for Prostate Cancer Treatment in India

JCI NABH
311 Beds
15 OTs
100+ ICU

Fortis Memorial Research Institute is a JCI-accredited quaternary-care hospital in Gurgaon, consistently ranked among India's top 5 smart hospitals, handling the country's most complex referral cases in cardiac, neurology, and oncology.

Medanta — The Medicity

JCI NABH NABL
1,391 Beds
40 OTs
270+ ICU

Medanta — The Medicity in Gurgaon is India's highest-ranked private hospital, treating over 20,000 international patients annually from 130 countries, with 1,391 beds and 40 operating theatres across a 43-acre campus.

JCI NABH NABL
530 Beds
20 OTs
100+ ICU

Max Super Speciality Hospital Saket is one of New Delhi's leading multi-specialty hospitals, home to the first intraoperative MRI in India and the largest oncology programme in Delhi.

Indraprastha Apollo Hospital

JCI NABH NABL
710 Beds
52 OTs
110+ ICU

Indraprastha Apollo Hospital in New Delhi was India's first JCI-accredited hospital, maintaining this distinction since 1996. With 710 beds and 52 operating theatres, it is one of Delhi's most comprehensive multi-specialty hospitals serving international patients from the Gulf and Middle East.

👨‍⚕️ Top Cancer Treatment Doctors in India

Dr. Naresh Trehan Hod

Dr. Naresh Trehan

Chairman & Managing Director
56+ Years Experience 48,000+ surgeries
JCI, NABH, NABL
No Image

Dr. Ashok K. Vaid

Chairman — Oncology, Haematology & Stem Cell Transplant
41+ Years of Experience Stem Cell Transplant
Precision Oncology Pioneer
No Image

Dr. Ashok Rajgopal

Group Chairman — Orthopaedics & Joint Replacement
35+ Years of Experience 39,000+ Knee Replacements
No Image

Dr. Ashok Seth

Chairman — Interventional Cardiology
38+ Years of Experience 50,000+ Angiograms

Frequently Asked Questions

Robotic prostatectomy: $6,000–$9,000. HIFU: $5,000–$8,000. IMRT radiation: $5,000– $10,000. Hormone therapy/month: $200–$500. All 65–80% less than Gulf.

Yes. Da Vinci robotic system available. Surgeons with 1,000+ robotic prostatectomies. Nerve-sparing technique preserves urinary function.

Non-invasive ultrasound treatment that destroys cancer cells without surgery. Ideal for localised prostate cancer. Most patients go home same day.

Robotic prostatectomy: 7–10 days. HIFU: 3–5 days. SBRT radiation: 2 weeks. Hormone injections continued at home.

Yes. Active surveillance is an option for very low-risk early prostate cancer. Oncologists will assess suitability.

Start Your Treatment Journey Today